Spark Therapeutics (ONCE) – Reuters
-
FTC staff recommends approval of Roche deal for Spark: report
-
Roche CEO touts drugs pipeline, rules out M&A just to boost sales
-
Roche, Spark again extend $4.3 billion takeover offer
-
Roche, Spark push back takeover deadline in $4.3 billion deal
-
Express Scripts staking out million-dollar gene therapies
Back to ONCE Stock Lookup